Indian pharma growth decelerated in March but expect good future growth, says CLSA
Updated : April 16, 2019 10:37 AM IST
Glenmark and Lupin have been delivering fast growth with March 19 sales rising 10.2 percent, according to the report,
Cipla’s growth was aided by seasonal factors while Torrent moved ahead of the market at 8 percent in March, CLSA said.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more